Bluejay Diagnostics, Inc. financial data

Symbol
BJDX on Nasdaq
Location
360 Massachusetts Avenue, Suite 203, Acton, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 384 % +10.4%
Debt-to-equity 25 % -22.1%
Return On Equity -147 % +5.25%
Return On Assets -118 % -0.12%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.81M shares -93.3%
Common Stock, Shares, Outstanding 1.64M shares -90.8%
Entity Public Float 1.7M USD -43.9%
Common Stock, Value, Issued 164 USD -90.8%
Weighted Average Number of Shares Outstanding, Basic 1.57M shares +724%
Weighted Average Number of Shares Outstanding, Diluted 1.57M shares +724%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3.01M USD -28.4%
Selling and Marketing Expense 8.3K USD
General and Administrative Expense 3.96M USD +2.69%
Operating Income (Loss) -6.98M USD +13.6%
Nonoperating Income (Expense) 125K USD
Net Income (Loss) Attributable to Parent -6.85M USD +20.2%
Earnings Per Share, Basic 607 USD/shares +98.7%
Earnings Per Share, Diluted 607 USD/shares +98.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.08M USD -46.4%
Assets, Current 3.35M USD -48.9%
Property, Plant and Equipment, Net 1.39M USD -9.17%
Operating Lease, Right-of-Use Asset 135K USD -40.8%
Other Assets, Noncurrent 8.73K USD -63%
Assets 4.89M USD -41.5%
Accounts Payable, Current 161K USD -49.1%
Accrued Liabilities, Current 552K USD -50.6%
Liabilities, Current 1.15M USD +9.5%
Operating Lease, Liability, Noncurrent 43K USD -67%
Other Liabilities, Noncurrent 5.57K USD -41.5%
Liabilities 1.2M USD +0.72%
Retained Earnings (Accumulated Deficit) -40.1M USD -20.6%
Stockholders' Equity Attributable to Parent 3.69M USD -48.5%
Liabilities and Equity 4.89M USD -41.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.18M USD +48.5%
Net Cash Provided by (Used in) Financing Activities -985K USD -135%
Net Cash Provided by (Used in) Investing Activities -35.4K USD +89.6%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 1.64M shares -90.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.08M USD -46.4%
Deferred Tax Assets, Valuation Allowance 10M USD +30.4%
Deferred Tax Assets, Gross 10M USD +30.4%
Operating Lease, Liability 143K USD -40.8%
Depreciation 18.4K USD -6.66%
Payments to Acquire Property, Plant, and Equipment 35.4K USD -89.6%
Lessee, Operating Lease, Liability, to be Paid 150K USD -42.6%
Property, Plant and Equipment, Gross 1.51M USD -46.6%
Operating Lease, Liability, Current 100K USD -10.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25K USD -75%
Lessee, Operating Lease, Liability, to be Paid, Year One 100K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.01K USD -64.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 6.36M USD +39.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 25K USD -75%
Operating Lease, Payments 38.3K USD -13.5%
Additional Paid in Capital 28.7M USD +1.48%
Share-based Payment Arrangement, Expense -2.65K USD -137%
Interest Expense 186K USD